2CD-2,5-DiEtO

Pharmaceutical compound From Wikipedia, the free encyclopedia

2CD-2,5-DiEtO, also known as 2,5-diethoxy-4-methylphenethylamine, is a psychoactive drug of the phenethylamine, 2C, and TWEETIO families related to the psychedelic drug 2C-D.[1][2][3] It is the derivative of 2C-D in which the methoxy groups at the 2 and 5 positions have been replaced with ethoxy groups.[1][2][3]

Other names2CD-DiEtO; 2CD-Di-EtO; 2CD-DIETO; 2CD-DI-ETO; 2,5-Diethoxy-4-methylphenethylamine; 4-Methyl-2,5-diethoxyphenethylamine
ATC code
  • None
Quick facts Clinical data, Other names ...
2CD-2,5-DiEtO
Clinical data
Other names2CD-DiEtO; 2CD-Di-EtO; 2CD-DIETO; 2CD-DI-ETO; 2,5-Diethoxy-4-methylphenethylamine; 4-Methyl-2,5-diethoxyphenethylamine
Routes of
administration
Oral[1][2][3]
Drug classPsychoactive drug
ATC code
  • None
Pharmacokinetic data
Duration of action4 hours[1][2][3]
Identifiers
  • 2-(2,5-diethoxy-4-methylphenyl)ethan-1-amine
Chemical and physical data
FormulaC13H21NO2
Molar mass223.316 g·mol−1
3D model (JSmol)
  • CCOC1=CC(CCN)=C(OCC)C=C1C
  • InChI=1S/C13H21NO2/c1-4-15-12-9-11(6-7-14)13(16-5-2)8-10(12)3/h8-9H,4-7,14H2,1-3H3
  • Key:ALVWRNQBQUMSMA-UHFFFAOYSA-N
Close

According to Alexander Shulgin in his book PiHKAL (Phenethylamines I Have Known and Loved) and other publications, 2CD-2,5-DiEtO's dose is greater than 55 mg orally and its duration is 4 hours.[1][2][3] 2CD-2,5-DiEtO has been described as producing mild effects that were no greater than a "plus-one" on the Shulgin Rating Scale.[1][2][3] No specific effects have been described and higher doses were not tested.[1][2][3]

The chemical synthesis of 2CD-2,5-DiEtO has been described.[1]

2CD-2,5-DiEtO was first described in the literature by Shulgin in PiHKAL in 1991.[1] It was developed and tested by Darrell Lemaire, with publication via personal communication with Shulgin.[2][4][5][6][7] The drug is a controlled substance in Canada under phenethylamine blanket-ban language.[8]

See also

References

Related Articles

Wikiwand AI